DiscoverSpringer Health+ IME: Podcast to PracticeReal-world data on anti-amyloid antibody therapies | S1E9
Real-world data on anti-amyloid antibody therapies | S1E9

Real-world data on anti-amyloid antibody therapies | S1E9

Update: 2024-11-13
Share

Description

New era for Alzheimer's disease

As part of our independent medical education program, featuring conference coverage in the rapidly progressing field of Alzheimer's Disease, we bring you the latest news and updates from the major neurology congresses throughout 2024.


Direct from CTAD 2024 Claire Paquet presents this episode on the implications of real-world and recommendation data on anti-amyloid antibody therapies for Alzheimer's disease.


This activity is supported by an educational grant from Lilly.---
To learn more about the full program covering key conferences in 2024 visit https://new-era-alzheimers-disease.im.springerhealthcare.com

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Real-world data on anti-amyloid antibody therapies | S1E9

Real-world data on anti-amyloid antibody therapies | S1E9

Springer Health+ IME